DR. MIRDZA ERIKA NEIDERS, DDS
Dentist at Squire Hall, Buffalo, NY
License number
New York 24127
Category
Dentist
Type
Oral and Maxillofacial Pathology
Address
Address
2
3435 Squire Hall, Buffalo, NY 14214
181 Smalwood Dr., Amherst, NY 14226
181 Smalwood Dr., Amherst, NY 14226
Phone
(716) 829-2054
(716) 829-3554 (Fax)
(716) 829-3554 (Fax)
Personal information
See more information about MIRDZA ERIKA NEIDERS at radaris.comName
Address
Phone
181 Smallwood Dr, Amherst, NY 14226
181 Smallwood Dr, Snyder, NY 14226
Professional information
See more information about MIRDZA ERIKA NEIDERS at trustoria.com
Dr. Mirdza E Neiders, Buffalo NY - DDS (Doctor of Dental Surgery)
Dr. Mirdza E Neiders, Buffalo NY - DDS (Doctor of Dental Surgery)
Specialties:
Oral & Maxillofacial Pathology
Address:
3435 Main St, Buffalo 14214
(716) 829-2054 (Phone), (716) 829-3554 (Fax)
(716) 829-2054 (Phone), (716) 829-3554 (Fax)
Languages:
English
Mirdza Erika Neiders, Buffalo NY
Mirdza Erika Neiders, Buffalo NY
Specialties:
Dentist
Address:
3435 Main St, Buffalo, NY 14214
Monoclonal Antibodies Useful In The Identification Of Microorganisms Causing Periodontal Disease
Monoclonal Antibodies Useful In The Identification Of Microorganisms Causing Periodontal Disease
US Patent:
4741999, May 3, 1988
Filed:
Feb 26, 1986
Appl. No.:
6/833856
Inventors:
Robert J. Genco - Buffalo NY
Joseph J. Zambon - Williamsville NY
Lars A. Christersson - Snyder NY
Mirdza E. Neiders - Amherst NY
Joseph J. Zambon - Williamsville NY
Lars A. Christersson - Snyder NY
Mirdza E. Neiders - Amherst NY
Assignee:
The Research Foundation of State University of New York - Albany NY
International Classification:
C12N 500, C12N 1500, G01N 33569, G01N 33577
US Classification:
435 7
Abstract:
Actinobacillus actinomycetemcomitans has frequently been implicated in juvenile periodontitis. The present monoclonal antibodies are specific to Actinobacillus actinomycetemcomitans. The present monoclonal antibodies are typically employed as reagents which include an inert carrier, preferably a liquid, such as buffered saline solution and a preservative. The carrier compositions are suitably selected to provide for the proper dispersal of bacteria, and to preserve the integrity of antigens and supplemental structures. The selection of the proper carrier is especially important in the detection in mixtures which include bacteria which produce large amounts of autolyltic enzymes such as B. gingivalis. The monoclonal antibodies of the present invention are useful in clinical testing and differentiating antigens in the gingival or subgingival sera.